Glucocorticoids Reduce Mortality in Community-Acquired Pneumonia

ADJUNCTIVE glucocorticoid therapy has shown promise in reducing mortality among patients with severe community-acquired pneumonia (CAP) in well-resourced settings. However, evidence for its effectiveness in low-resource environments has been…